Related Experiment Video
Updated: Jul 6, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2
Paolo Parini1, Ulf Gustafsson, Matt A Davis
1Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Objective:
The purpose of this study was to identify how different degrees of cholesterol synthesis inhibition affect human hepatic cholesterol metabolism.
Methods And Results:
Thirty-seven normocholesterolemic gallstone patients randomized to treatment with placebo, 20 mg/d fluvastatin, or 80 mg/d atorvastatin for 4 weeks were studied. Based on serum lathosterol determinations, cholesterol synthesis was reduced by 42% and 70% in the 2 groups receiving statins. VLDL cholesterol was reduced by 20% and 55%. During gallstone surgery, a liver biopsy was obtained and hepatic protein and mRNA expression of rate-limiting steps in cholesterol metabolism were assayed and related to serum lipoproteins. A marked induction of LDL receptors and 3-hydroxy-3-methylglutaryl (HMG) coenzyme A (CoA) reductase was positively related to the degree of cholesterol synthesis inhibition (ChSI). The activity, protein, and mRNA for ACAT2 were all reduced during ChSI, as was apoE mRNA. The lowering of HDL cholesterol in response to high ChSI could not be explained by altered expression of the HDL receptor CLA-1, ABCA1, or apoA-I.
Conclusions:
Statin treatment reduces ACAT2 activity in human liver and this effect, in combination with a reduced Apo E expression, may contribute to the favorable lowering of VLDL cholesterol seen in addition to the LDL lowering during statin treatment.
Insights
Statin therapy significantly impacts cholesterol metabolism by reducing cholesterol synthesis and ACAT2 activity in the liver. This contributes to favorable reductions in VLDL and LDL cholesterol levels.
Area of Science:
- Biochemistry
- Human Metabolism
- Pharmacology
Background:
- Cholesterol homeostasis is tightly regulated by synthesis and uptake pathways.
- Statins are widely used to lower cholesterol but their precise effects on hepatic metabolism require further elucidation.
Purpose of the Study:
- To investigate the impact of varying degrees of cholesterol synthesis inhibition on human hepatic cholesterol metabolism.
- To correlate changes in hepatic gene and protein expression with serum lipoprotein levels.
Main Methods:
- A randomized controlled trial involving 37 patients treated with placebo, fluvastatin, or atorvastatin for 4 weeks.
- Measurement of cholesterol synthesis inhibition (ChSI) via serum lathosterol.
- Analysis of liver biopsy samples for protein and mRNA expression of key metabolic enzymes and receptors.
Main Results:
- Statins reduced cholesterol synthesis by 42-70%, leading to decreased VLDL cholesterol (20-55%).
- Increased LDL receptor and HMG-CoA reductase expression correlated with ChSI.
- Reduced ACAT2 activity and ApoE mRNA were observed with cholesterol synthesis inhibition.
Conclusions:
- Statin-induced reduction in hepatic ACAT2 activity and ApoE expression contribute to decreased VLDL cholesterol.
- These hepatic changes complement the LDL-lowering effects of statins.
More Related Videos
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Lipid Catabolism
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...

